Loren Data's SAM Daily™

FBO DAILY - FEDBIZOPPS ISSUE OF SEPTEMBER 23, 2018 FBO #6148
SOLICITATION NOTICE

65 -- Reagents and consumables for the Miltenyi Clinimacs implementation

Notice Date

9/21/2018
 

Notice Type

Combined Synopsis/Solicitation
 

NAICS

334516 — Analytical Laboratory Instrument Manufacturing
 

Contracting Office

Department of Health and Human Services, National Institutes of Health, NCATS, National Institute on Drug Abuse, National Center for Advancing Translational Science (NCATS), 6001 Executive Boulevard, Bethesda, Maryland, 20892, United States
 

ZIP Code

20892
 

Solicitation Number

NIHTS201800001
 

Archive Date

10/11/2018
 

Point of Contact

Brian Lind, Phone: 3015948939
 

E-Mail Address

brian.lind@nih.gov
(brian.lind@nih.gov)
 

Small Business Set-Aside

N/A
 

Description

NON-COMPETITIVE COMBINED SYNOPSIS / SOLICITATION This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. (ii) The solicitation number is NIHTS201800001 and the solicitation is issued as a Request For Quotation (RFQ) This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures; FAR Subpart 13.5-Simplified Procedures for Certain Commercial Items; and FAR Part 12-Acquisition of Commercial Items, and is not expected to exceed the simplified acquisition threshold. THIS IS A NON-COMPETITIVE (NOTICE OF INTENT) COMBINED SYNOPSIS SOLICITATION TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). The National Center for Advancing Translational Science intends to negotiate and award a Purchase Order without providing for full and open competition (Including brand-name) to Miltenyi Biotec, 2303 Lindbergh Street, Auburn, CA 95602 for Reagents and consumables for the Miltenyi Clinimacs implementation. This acquisition is conducted as non-competitive for a commercial item or service and is conducted under the authority of the FAR Subpart 13.5-Simplified Procedures for Certain Commercial Items and 13.501 Special documentation requirements and the authority of 41 U.S.C. 1901 and the statutory authority of FAR 6.302-3(a)(2)(ii). Pursuant to FAR Subpart 13.501 (a) (1) (iv) the rationale for the brand name justification is that the manufacturer requires these reagents and consumables for the installation and implementation of the unit. Any use of any other brand or equal product can void any warranties. (iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2005-100 dated 08-22-2018.. (iv) The associated NAICS code 334516 and the small business size standard 1000. This requirement has no set aside restrictions. (v)The purchase is for reagents needed to for implementation and use of the Miltenyi CliniMACS for engineering immune cells. These items for the Miltenyi CliniMACS platform, and include bead, antibody reagents, and buffers as follows; 130-030-401 304-01 - CliniMACS CD4 MicroBeads - 1 vial 7,5 mL, For research use only, not for use in humans - 2 ea 130-030-801 308-01 - CliniMACS CD8 MicroBeads - 1 vial 7,5 mL. For research use only, not for use in humans - 2 ea 170-076-147 - MACS GMP Recombinant Human IL-2, 1 vial 500 μg - 1ea 130-019-011 - MACS GMP T Cell TransAct, RUO, 1 vial 4 mL 1ea 130-070-525 705-25 - CliniMACS PBS/EDTA Buffer for research use contents: 3 x 1L plastic bags, sterile, non-pyrogenic - 2 ea 130-021-201 212-01 - CliniMACS PBS/EDTA Buffer for Research Use consists of: 2 x 3L plastic bags, sterile, non-pyrogenic, 2 PC. 170-076-306 - TexMACS GMP Medium 1 bag 2000mL, 4 PC. 170-076-111 - MACS GMP Recombinant Human IL-7 1 vial 25 μg, 1 PC. 170-076-114 - MACS GMP Recombinant Human IL-15 1 vial 25 μg, 1 PC. (vi) Deliver to: NCATS Chemical Genomics Center (NCGC) National Institutes of Health 9800 Medical Center Drive Rockville, MD 20850 Office: 301-480-9928 (viii) The provision at FAR clause 52.212-1, Instructions to Offerors - Commercial Items, applies to this acquisition. (ix)The provision at FAR clause 52.212-2, Evaluation - Commercial Items, applies to this acquisition. (a)A written notice of award or acceptance of an offer, mailed or otherwise furnished to the successful offeror within the time for acceptance specified in the offer, shall result in a binding contract without further action by either party. Before the offer's specified expiration time, the Government may accept an offer (or part of an offer), whether or not there are negotiations after its receipt, unless a written notice of withdrawal is received before award. (x)The Offerors to include a completed copy of the provision at FAR clause 52.212-3, Offeror Representations and Certifications-Commercial Items, with its offer. (xi)The FAR clause at 52.212-4, Contract Terms and Conditions - Commercial Items, applies to this acquisition. (xii)FAR clause at 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders-Commercial Items, applies to this acquisition. (xiii)The following additional contract requirement(s) or terms and conditions as determined by the contracting officer are necessary for this acquisition and consistent with customary commercial practices. NONE (xiv) The Defense Priorities and Allocations System (DPAS) are not applicable to this requirement. (xv) Responses to this solicitation must include sufficient information to establish the interested parties' bona-fide capabilities of providing the product or service. The price quote shall include: unit price, list price, shipping and handling costs, delivery days after contract award, delivery terms, prompt payment discount terms, F.O.B. Point (Destination or Origin), product or catalog number(s); product description; and any other information or factors that may be considered in the award decision. Such factors may include: past performance; special features required for effective program performance; trade-in considerations; probable life of the item selected as compared with that of a comparable item; warranty considerations; maintenance availability; and environmental and energy efficiency considerations. Respondents that believe that they are manufacturers or authorized resellers of the brand-name product specified in this announcement must provide, as part of their response: (a) product, catalog, model, and/or part number(s); (b) product description; (c) all relevant information and documentation that the item(s) offered meets the salient physical, functional, or performance characteristics as specified in the purchase description; quantity; estimated price or cost; shipping, handling, and/or installation charges; and delivery date after receipt of order. In addition the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size must be included in the response. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov." All responses must be received by September 26, 2018 @ 9:00 AM (EST) and reference number NIHTS201800001. Responses may be submitted electronically to brian.lind@nih.gov. Fax responses will not be accepted.
 

Web Link

FBO.gov Permalink
(https://www.fbo.gov/notices/31b40177250cff65e8e24333d98d64e2)
 

Place of Performance

Address: NCATS Chemical Genomics Center (NCGC), National Institutes of Health, 9800 Medical Center Drive, Rockville, Maryland, 20850, United States

Zip Code: 20850
 

Record

SN05101147-W 20180923/180921231047-31b40177250cff65e8e24333d98d64e2 (fbodaily.com)
 

Source

FedBizOpps Link to This Notice
(may not be valid after Archive Date)

---

| FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |